BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center For Technology Licensing - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ctl.cornell.edu
X-WR-CALDESC:Events for Center For Technology Licensing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260423T120000
DTEND;TZID=America/New_York:20260423T180000
DTSTAMP:20260429T044509
CREATED:20260410T204140Z
LAST-MODIFIED:20260410T204140Z
UID:10000599-1776945600-1776967200@ctl.cornell.edu
SUMMARY:2026 BioInnovate Conference
DESCRIPTION:Join the 2026 BioInnovate Conference\, a curated forum connecting life sciences investors and industry leaders with promising spinouts from Weill Cornell Medicine\, Cornell University\, and Cornell Tech. \nThis event brings together academic inventors\, early-stage investors\, industry leaders\, and startup executives to spark new connections\, explore partnerships\, and advance translational innovation. This year’s audience includes 40+ specialist biomedical investors and industry representatives. \nFeatured guests include: \n\nMichael Foley\, PhD\, CEO & Co-Founder\, Excelsior Sciences\nAdam Volini\, Executive Director & VP\, Life Sciences & Strategic Partnerships\, NYS Empire State Development\nHenry Wei\, MD ’02\, Head of Development Innovation\, Regeneron\n\nStartup pitches from: \n\nAstoria Biologica – first-in-class multiple sclerosis therapeutic\nNeuroTwain – digital clinical decision support tool for neurological diseases\n\nThe program will also include the announcement of the Resnick Prize for Excellence in Entrepreneurship and additional awards. \nOver the years\, BioInnovate has catalyzed venture financings\, industry partnerships\, and leadership team formation for emerging companies across the Cornell innovation ecosystem. \nIf you are in NYC\, join us at Uris Auditorium on the Weill Cornell campus starting at noon. In-person registration here. \nIf you are in Ithaca or anywhere else\, join us online from 3-6 PM (ET). Virtual registration here.
URL:https://ctl.cornell.edu/event/2026-bioinnovate-conference
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2026/04/2026-BioInnovate-Conference-Graphic-e1775853664391.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260318T140000
DTEND;TZID=UTC:20260318T160000
DTSTAMP:20260429T044509
CREATED:20260315T162650Z
LAST-MODIFIED:20260315T162650Z
UID:10000596-1773842400-1773849600@ctl.cornell.edu
SUMMARY:CTL@WCM Office Hours With Brian Kelly
DESCRIPTION:CTL@WCM Virtual Office Hours are open to all who wish to gain more information about the advancement of their personal projects with a one-on-one meeting with a Weill Cornell Business and Licensing Officer. \nMarch 18th office hours will be hosted by Brian Kelly\, the Director of Technology Licensing at the CTL NYC office. \nBrian manages a portfolio of inventions focusing on oncology\, metabolic diseases\, and endocrine disorders. Brian has primary responsibility for Biochemistry\, Genetic Medicine\, Pharmacology\, Institute for IBD\, and Dermatology. \nReserve your 30-minute slot between 2-4 pm. Register here.
URL:https://ctl.cornell.edu/event/ctlwcm-office-hours-with-brian-kelly-3-2026
CATEGORIES:CTL Office Hours
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/03/Brian-Office-Hours-web-image.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251209T173000
DTEND;TZID=America/New_York:20251209T200000
DTSTAMP:20260429T044509
CREATED:20251126T204604Z
LAST-MODIFIED:20251126T204604Z
UID:10000581-1765301400-1765310400@ctl.cornell.edu
SUMMARY:Accelerating BioVenture Innovation Final Pitch Event
DESCRIPTION:Weill Cornell Medicine Enterprise Innovation invite you to join on Tuesday\, December 9\, 5:30-8pm as the finalist teams from the 2025 Accelerating BioVenture Innovation course pitch their technologies to a panel of early-stage investors and industry judges. \nThe pitch event will take place at Uris Auditorium\, 1300 York Ave\, New York\, NY\, followed by a networking reception at Griffis Faculty Lounge with investors\, ecosystem partners and industry representatives who served as mentors and lecturers throughout the program. Celebrate the winning teams and scientific innovation with hors d’oeuvres and cocktails! \nRSVP here. \nAbout Accelerating BioVenture Innovation: \nAccelerating BioVenture Innovation (ABI) is a 15-week experiential course in innovation and entrepreneurship that builds teams around patented technologies from local academic institutions and federal laboratories. The program educates participants on all aspects of commercializing an academic invention. Teams create pitch decks after weeks of instruction and mentorship from industry experts\, and then finalist teams are selected to pitch to a panel of investors and industry judges.
URL:https://ctl.cornell.edu/event/accelerating-bioventure-innovation-final-pitch-event-2025
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/jpeg:https://ctl.cornell.edu/wp-content/uploads/2025/11/ABI-Final-Pitch-with-Speakers.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251117T135000
DTEND;TZID=America/New_York:20251117T170000
DTSTAMP:20260429T044509
CREATED:20251029T213720Z
LAST-MODIFIED:20251029T213720Z
UID:10000578-1763387400-1763398800@ctl.cornell.edu
SUMMARY:Weill Cornell Medicine Symposium on Innovation and Entrepreneurship 2025
DESCRIPTION:Weill Cornell Medicine Dean’s Office and Enterprise Innovation invite you to join us virtually\nfor an afternoon filled with insightful discussions on biomedical innovation and\nentrepreneurship and a celebration of our innovator-entrepreneurs. This symposium\nfeatures a fireside chat with Dean Robert A. Harrington and Barry Kappel\, Ph.D. ’06\, M.B.A.\,\nFounder\, President\, CEO & Director of Sapience Therapeutics. \nRSVP here.
URL:https://ctl.cornell.edu/event/weill-cornell-medicine-symposium-on-innovation-and-entrepreneurship-2025
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2025/10/WCM-Ninth-Deans-Symposium.png
LOCATION:https://ctl.cornell.edu/event/weill-cornell-medicine-symposium-on-innovation-and-entrepreneurship-2025
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250415T140000
DTEND;TZID=America/New_York:20250415T160000
DTSTAMP:20260429T044509
CREATED:20250401T154758Z
LAST-MODIFIED:20250401T154758Z
UID:10000566-1744725600-1744732800@ctl.cornell.edu
SUMMARY:WCM Office Hours with Eric Bryant
DESCRIPTION:Eric holds a Master of Science in Biomedical Engineering from New York University (NYU)\, a Juris Doctor from New York Law School\, and is a registered patent attorney. He works with the Weill Cornell office to execute on intellectual property strategy\, review submitted invention disclosures\, and manage domestic and foreign patent filings and patent prosecution. Eric’s expertise encompasses a variety of technologies including\, but not limited to\, diagnostics tools and methods\, pharmaceuticals\, controlled release therapeutic devices\, respiratory devices\, surgical tools\, biological technologies and nanotechnology. \nTo reserve your 30-minute Zoom office hours session\, click on the registration button below and select your preferred time. You will be given access to a Zoom registration link and will meet privately with Eric within that Zoom session. \nBook with Eric on April 15 from 2-4 p.m. on Zoom. \n 
URL:https://ctl.cornell.edu/event/wcm-office-hours-with-eric-bryant
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240228T100000
DTEND;TZID=America/New_York:20240228T170000
DTSTAMP:20260429T044509
CREATED:20240205T142639Z
LAST-MODIFIED:20240205T142639Z
UID:10000482-1709114400-1709139600@ctl.cornell.edu
SUMMARY:Annual Weill Cornell Medicine Startup Symposium & InvestConnect Conference
DESCRIPTION:You are invited to join the annual Weill Cornell Medicine Startup Symposium & InvestConnect Conference on Wednesday\, February 28\, 10:00 a.m.- 5:00 p.m. ET.  This full-day program is an opportunity to celebrate innovation &  entrepreneurship and engage with like-minded founders\, investors and industry representatives. Featured presentations will include: \n– An interview with Bruce R.\, Weill Cornell Medicine Board of Fellows member\, and Adam Bonislawski\, Editor with GenomeWeb\, co-authors of Early Detection: Catching Cancer When It’s Curable. In addition to being a prolific NYC real estate developer and philanthropist\, Mr. Ratner is the founder of the Michael D. Ratner Center for Early Detection of Cancer\, a non-profit established in the name of his older brother who passed away from metastatic cancer. He also sits on the boards of Memorial Sloan Kettering Cancer Center and the Cold Spring Harbor Laboratory. This lunchtime interview will be moderated by John Leonard\, M.D.\, Senior Associate Dean for Innovation and Initiatives. \n– A discussion on therapeutics with Barry Kappel\, Ph.D. ‘06\, Founder\, President & CEO of Sapience Therapeutics\, Inc. \n– An update on a novel neurotech startup being formed by Nicholas D. Schiff\, M.D. ’92\, the Jerald B. Katz Professor of Neurology and Neuroscience and Professor of Neuroscience at the Brain and Mind Research Institute. \n– A company update from Bernard Peperstraete\, MD\, MBA\, Co-Founder\, President & CEO of Acuamark Diagnostics\, Inc.\, a liquid biopsy company that is optimizing qPCR and dPCR for early detection of cancer. \nThe conference takes place on-campus at Belfer Research Building\, 413 E 69th St and will feature a startup expo and networking reception. Don’t miss out on an opportunity to meet WCM innovators and make impactful industry connections! \nhttps://2024startupsymposiumwcm.splashthat.com/
URL:https://ctl.cornell.edu/event/annual-weill-cornell-medicine-startup-symposium-investconnect-conference
CATEGORIES:CTL Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2024/02/Screenshot-2024-02-05-at-9.23.35-AM.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231130T100000
DTEND;TZID=America/New_York:20231130T120000
DTSTAMP:20260429T044509
CREATED:20231129T042939Z
LAST-MODIFIED:20231129T044626Z
UID:10000474-1701338400-1701345600@ctl.cornell.edu
SUMMARY:Manufacturing Considerations in Drug Development
DESCRIPTION:Thursday\, November 30\, 10-12 pm: Weill Cornell Medicine BioVenture eLab\, a part of Weill Cornell Medicine Enterprise Innovation\, invites WCM faculty and trainees working in drug development to join an educational program focused on designing an R&D and manufacturing plan for your innovation. \nFeaturing Catalent Pharma Solutions\, a renowned global CDMO that partners with pharma and biotech companies to accelerate and lead development\, the program will include two presentations – one focused on biologics and another on small molecules. Following the presentations\, the Catalent representatives will be available to meet 1:1 with you and your team to offer tailored mentoring for your specific project. \nPresentations: 10-12 pm (Hybrid) \n– Biologics Presentation: Strategic Considerations in Biologics CMC Development to Ensure Successful Path to IND \n– Small Molecules Presentation: Streamlining Formulation and Delivery of Small Molecules in Early Development \n– 1:1 Meetings: 12:30-5pm (In-person) – You need to register for the program in order to schedule a 1:1 appointment. \nThis is a hybrid program where the presentation portion will take place at BioVenture eLab\, 1157 York Ave\, and will include a Zoom option. However\, please note that 1:1 meetings will be in-person only and will be held at Belfer Research Building (413 E 69th St) from 12:30-5 pm. \nRegister now
URL:https://ctl.cornell.edu/event/manufacturing-considerations-in-drug-development
ATTACH;FMTTYPE=image/jpeg:https://ctl.cornell.edu/wp-content/uploads/2023/11/https___cdn.evbuc_.com_images_643192369_1043578448253_1_original.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230829T173000
DTEND;TZID=America/New_York:20230829T203000
DTSTAMP:20260429T044509
CREATED:20230812T225526Z
LAST-MODIFIED:20230812T225632Z
UID:10000441-1693330200-1693341000@ctl.cornell.edu
SUMMARY:Accelerating BioVenture Innovation Kick-Off
DESCRIPTION:We formally invite you to join Weill Cornell Medicine and the greater NYC life science startup community for the kick-off of our Accelerating BioVenture Innovation accelerator with special guest – Erandi De Silva\, PhD\, Co-Founder & Senior Vice President of Product Development at Forge Biologics!  Dr. De Silva was selected by Fierce Pharma as one of its 2022 Fiercest Women in Life Sciences. We are excited to have her on campus to share her personal story and startup journey. \nThe event is scheduled for Tuesday\, August 29\, 5:30-8:30pm. It will take place in-person at Uris Auditorium\, 1300 York Avenue @ 69th Street\, and will be followed by a networking reception with cocktails in Griffis Faculty Lounge (same location). This is a great opportunity to meet like-minded faculty\, trainees and clinicians interested in translational science and medicine.  \nRegister HERE \n\nAbout Forge Biologics \nForge Biologics is a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company. Forge’s mission is to enable access to life-changing gene therapies and help bring them from idea to reality. Forge’s 200\,000 square foot facility utilizes 20 cGMP suites in Columbus\, Ohio\, the Hearth\, to serve as its headquarters. The Hearth is a custom-designed cGMP facility dedicated to AAV manufacturing and hosts scalable\, end-to-end manufacturing services. Offerings include process and analytical development\, plasmid DNA manufacturing\, viral vector manufacturing\, final fill\, as well as regulatory consulting support to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. Investors include Drive Capital\, Perceptive Xontogeny Venture Fund\, RA Capital Management\, Surveyor Capital (a Citadel company)\, Octagon Capital\, Marshall Wace\, and Aisling Capital. By taking a patients-first approach\, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most. To learn more\, visit www.forgebiologics.com. \n About Accelerating BioVenture Innovation  \nABI is a training program for life science postdocs/trainees\, PhD students\, and medical school students. The 15-week program builds teams around patented technologies from Weill Cornell Medicine\, Memorial Sloan Kettering Cancer Center and Rockefeller University. Teams develop business plans in the form of an investor pitch around these technologies. The teams are matched with MBA students and biotech industry professionals to broaden their business acumen and promote collaboration. Weekly lectures cover various startup fundamentals. At the end of the course\, the teams compete in a final pitch event with institutional VCs and angel investors as judges. If you are interested in participating in this Fall course\, please register here.
URL:https://ctl.cornell.edu/event/accelerating-bioventure-innovation-kick-off
LOCATION:Uris Auditorium\, 1300 York Avenue\, New York\, 10065\, United States
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/08/Events-page-image-size-700x500px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230601T173000
DTEND;TZID=America/New_York:20230601T203000
DTSTAMP:20260429T044509
CREATED:20230428T183503Z
LAST-MODIFIED:20230525T192918Z
UID:10000380-1685640600-1685651400@ctl.cornell.edu
SUMMARY:2023 Biomedical Business Plan Challenge Final Pitch Event
DESCRIPTION:Join the Weill Cornell Medicine community for a night of cocktails and networking to celebrate the successful completion of the Business Plan Challenge program by our ambitious newcos. In this highly selective program\, these faculty-led newcos complete 12 weeks of seminars led by subject matter experts. The topics include market concepts\, intellectual property\, R&D planning\, licensing/partnering\, budgeting/fundraising\, and others. Industry mentors are matched to the teams to support development of their business plans and finalization of their investor pitches. \nWe will kick-off the evening with pitches from each competing newco team\, and a panel of VC judges will choose winners for the $100K prize. Following judge deliberations\, an awards announcement and networking reception will commence. The event takes place on-site at Uris Auditorium and Griffis Faculty Club\, both located at 1300 York Avenue (@ 69th Street)\, New York\, NY 10065 \nAGENDA \n\nWelcome Remarks (Uris Auditorium) – Krystyn J. Van Vliet\, Vice President for Research and Innovation\, Cornell University.\nPitches (Uris Auditorium)\nJudge Deliberations & Awards Ceremony (Griffis Faculty Club)\nReception – Networking with cocktails and hors d’oeuvres (Griffis Faculty Club)\n\nJUDGES \n\nArtavazd (Artie) Arumov\, PhD – Vice President\, Qiming Ventures (US)\nUya Chuluunbaatar\, PhD – Partner\, Avoro Ventures\nSonia Gulati\, PhD – Principal\, Global BioAccess Fund\nCarlo Rizzuto\, PhD – Managing Director\, Versant Ventures\nMisti Ushio\, PhD – Managing Partner\, Digitalis Ventures\nColin (Leyi) Wang\, PhD – Managing Director\, 6 Dimensions Capital\n\nTEAMS \n\nMicroRNA therapeutics to treat obesity and high cholesterol\nCell therapy to treat insulin-dependent diabetes\nTherapeutics to treat multiple myeloma and solid tumors\nStem cell plasticity platform for treating a variety of diseases\nNovel small molecules for the treatment of metabolic diseases and cancer\nSingle-molecule nanoscopy platform for high-throughput\, real-time screening and imaging of live cells to be used in drug discovery\nProprietary therapeutic diet plans to fight against cancer and aging\n\nRegister here.
URL:https://ctl.cornell.edu/event/2023-biomedical-business-plan-challenge-final-pitch-event
LOCATION:Uris Auditorium\, 1300 York Avenue\, New York\, 10065\, United States
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/04/100K-Business-Plan-Challenge-Flyer-700-×-500-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230525T140000
DTEND;TZID=UTC:20230525T160000
DTSTAMP:20260429T044509
CREATED:20230515T204530Z
LAST-MODIFIED:20230515T204530Z
UID:10000386-1685023200-1685030400@ctl.cornell.edu
SUMMARY:CTL@WCM Office Hours With Donna Rounds
DESCRIPTION:CTL@WCM Virtual Office Hours are open to all who wish to gain more information about the advancement of their IP and commercialization projects with a one-on-one meeting with a Weill Cornell Business Development and Licensing Officer. \nThe May 25th office hours will be hosted by Donna Rounds\, Interim Senior Technology Licensing Officer at CTL\, NYC office\, from 2 – 4 p.m. \nDonna has over 20 years of building value in early-stage life science technologies—from sourcing emergent technologies to developing strategies for commercialization. \nShe specializes in: \n\nManaging complex scientific and business relationships\nLeveraging cross-functional teams in due diligence and technology assessments\nPrototype development\nProof-of-concept studies\n\nShe has a strong track record in successful outcomes through negotiation and transactions for licensing\, sponsored research\, and the creation of strategic alliances in pharma\, biotech\, and academia. Her passion is launching innovative projects into next-generation products for health and wellness care. \nRegister here.
URL:https://ctl.cornell.edu/event/ctlwcm-office-hours-with-donna-rounds-2
CATEGORIES:CTL Office Hours
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/03/Events-page-image-size-700x500px-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230511T120000
DTEND;TZID=America/New_York:20230511T130000
DTSTAMP:20260429T044509
CREATED:20230428T184733Z
LAST-MODIFIED:20230428T184733Z
UID:10000382-1683806400-1683810000@ctl.cornell.edu
SUMMARY:NY Ventures Virtual Info Session
DESCRIPTION:New York Ventures is the venture fund of New York State. It invests in teams that are using technology and innovation to solve important challenges in areas of strategic interest and importance to New York State. It actively looks to provide greater access to venture capital for regions\, industries and individuals\, including women and minority entrepreneurs. Its goal is to build a robust startup ecosystem across New York State\, leveraging public and private sector assets. \nThe agenda includes:: \n\nAn overview of NY Ventures\nInformation regarding NY Ventures’ pre-seed and seed matching fund\nQ&A\n\n*** Zoom link will be sent in confirmation email *** \nRegister here.
URL:https://ctl.cornell.edu/event/ny-ventures-virtual-info-session
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/04/Info-session-NY-Ventures-Events-page-image.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230505T120000
DTEND;TZID=America/New_York:20230505T130000
DTSTAMP:20260429T044509
CREATED:20230428T184050Z
LAST-MODIFIED:20230428T184050Z
UID:10000381-1683288000-1683291600@ctl.cornell.edu
SUMMARY:Early-Stage Communications Beyond the Investor Deck
DESCRIPTION:If your startup isn’t ready to pitch to investors\, how do you keep in contact with them and build a network for when you’re ready to raise capital? Join us to hear about the steps your startup can take now to begin early communications with investors and VCs. \n** Zoom link will be sent to attendees the week of the event ** \nRegister here.
URL:https://ctl.cornell.edu/event/early-stage-communications-beyond-the-investor-deck
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/04/Early-stage-communications-Events-page-image.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230420T140000
DTEND;TZID=UTC:20230420T160000
DTSTAMP:20260429T044509
CREATED:20230404T220603Z
LAST-MODIFIED:20230404T220603Z
UID:10000376-1681999200-1682006400@ctl.cornell.edu
SUMMARY:CTL@WCM Office Hours With Louise Sarup
DESCRIPTION:CTL@WCM Virtual Office Hours are open to all who wish to gain more information about the advancement of their IP and commercialization projects with a one-on-one meeting with a Weill Cornell Business Development and Licensing Officer. \nThe April 20th office hours will be hosted by Louise Sarup\, Interim Technology Licensing Officer at CTL\, NYC office\, from 2 – 4 p.m. \nLouise manages a portfolio of medical technologies focusing on imaging\, platform technologies\, and algorithms. She is a seasoned professional with years of experience in licensing and commercialization and is eager to answer your questions and provide valuable insights. \nReserve your 30-minute slot between 2-4 pm. Register here.
URL:https://ctl.cornell.edu/event/ctlwcm-office-hours-with-louise-sarup
CATEGORIES:CTL Office Hours
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/04/Louise-Office-Hours-Events-Page.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230403T093000
DTEND;TZID=America/New_York:20230403T103000
DTSTAMP:20260429T044509
CREATED:20230324T200326Z
LAST-MODIFIED:20230324T200326Z
UID:10000373-1680514200-1680517800@ctl.cornell.edu
SUMMARY:Alexandria LaunchLabs Breakfast at WCM Enterprise Innovation
DESCRIPTION:Alexandria LaunchLabs is hosting an information session and breakfast at Weill Cornell Medicine Enterprise Innovation’s eLab to talk about the $100\,000 Innovation Prize to be awarded at the Inaugural Alexandria Early-Stage Venture Summit in NYC on June 8\, 2023. Whitney Snider\, Alexandria’s VP\, will discuss about the prize\, investment insights\, and any other inquiries by the attendees. \nRegister here.
URL:https://ctl.cornell.edu/event/alexandria-launchlabs-breakfast-at-wcm-enterprise-innovation
LOCATION:Bioventure eLab\, 1157 York Avenue\, New York\, NY\, NY\, 10065\, United States
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/03/Alexandria-breakfast-2023.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230323T140000
DTEND;TZID=UTC:20230323T160000
DTSTAMP:20260429T044509
CREATED:20230303T015913Z
LAST-MODIFIED:20230307T030955Z
UID:10000366-1679580000-1679587200@ctl.cornell.edu
SUMMARY:CTL@WCM Office Hours With Brian Kelly
DESCRIPTION:CTL@WCM Virtual Office Hours are open to all who wish to gain more information about the advancement of their personal projects with a one-on-one meeting with a Weill Cornell Business and Licensing Officer. \nMarch 23rd office hours will be hosted by Brian Kelly\, the Director of Technology Licensing at the CTL NYC office. \nBrian manages a portfolio of inventions focusing on oncology\, metabolic diseases\, and endocrine disorders. Brian has primary responsibility for Biochemistry\, Genetic Medicine\, Pharmacology\, Institute for IBD\, and Dermatology. \nReserve your 30-minute slot between 2-4 pm. Register here. \nIn the event that the Office Hours for Brian Kelly are overbooked\, please submit your information on this form for direct scheduling.
URL:https://ctl.cornell.edu/event/ctlwcm-office-hours-with-brian-kelly-3
CATEGORIES:CTL Office Hours
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/03/Brian-Office-Hours-web-image.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230223T100000
DTEND;TZID=UTC:20230223T173000
DTSTAMP:20260429T044509
CREATED:20230131T024939Z
LAST-MODIFIED:20230131T025009Z
UID:10000338-1677146400-1677173400@ctl.cornell.edu
SUMMARY:2023 Weill Cornell Medicine Startup Symposium & InvestConnect Conference
DESCRIPTION:The 2023 Weill Cornell Medicine Startup Symposium & InvestConnect Conference is a full-day event where faculty founders\, investors\, and ecosystem partners convene to learn more about WCM innovations. \nThe morning program includes panel discussions and presentations directed to startup founders. This year\, the event will feature a fireside chat with a special guest\, Behzad Aghazadeh\, PhD’00\, Managing Partner\, Avoro Capital Advisors. The morning panel discussions and presentations are open to all conference registrants. \nThe afternoon program offers a hybrid forum for WCM founders to hold 1:1 meetings with early-stage investors. The meetings are pre-arranged using a technology platform hosted by BioVenture eLab. Use of the technology platform is by invitation only. \nAll conference registrants are welcome to interact with WCM founders during the Startup Showcase in the afternoon (2-5.30 pm). Startup Showcase will offer a forum for posters and technology demonstrations of WCM innovations. A cocktail reception will take place in the late afternoon (4-5.30 pm). \nThe Startup Symposium & InvestConnect Conference is an anchor program for attracting attention to Weill Cornell’s life science innovations. We look forward to welcoming you to our ecosystem\, be it through on-site or virtual participation. \n*The full benefits of the conference will be realized with on-site participation.* \n  \nEvent agenda can be found here. \nMore information and registration here.
URL:https://ctl.cornell.edu/event/2023-wcm-startup-symposium
LOCATION:Belfer Research Building\, 413 E 69th St\, New York\, NY\, NY\, 10021\, United States
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/01/WCM-Startup-SymposiumEvents-page-image-size-700x500px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230216T140000
DTEND;TZID=UTC:20230216T160000
DTSTAMP:20260429T044509
CREATED:20230207T213604Z
LAST-MODIFIED:20230208T000425Z
UID:10000356-1676556000-1676563200@ctl.cornell.edu
SUMMARY:CTL@WCM Office Hours
DESCRIPTION:CTL@WCM Office Hours are open to all who wish to get answers to their intellectual property questions and gain more information about how to advance their IP towards commercial partnership with a one-on-one meeting. \nOn Thursday\, February 16\, from 2 – 4 pm\, CTL is partnering with the Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) to answer WCM researchers’ questions about developing a novel therapeutic or drug. \nIf you have a potential therapeutic target and are looking for resources\, don’t miss this opportunity! Tri-I TDI’s mission is to translate groundbreaking biological discoveries by Memorial Sloan Kettering Cancer Center\, The Rockefeller University\, and Weill Cornell Medicine into novel small molecule or biological therapeutics. It provides industry-quality technical support for academic projects\, making it possible to rapidly assess the utility of specific therapeutics in disease-relevant contexts. TDI currently has an open call for proposals for new projects. \nTo reserve your 30-minute session\, click on the registration link below and select your preferred time. You will be given access to a Zoom registration link and meet privately with a CTL business development professional and a representative from Tri-I TDI matching your area of interest. \nRegister here.
URL:https://ctl.cornell.edu/event/ctlwcm-office-hours-tdi
CATEGORIES:CTL Office Hours
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/02/Events-page-image-size-700x500px-1-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230216T120000
DTEND;TZID=UTC:20230216T130000
DTSTAMP:20260429T044509
CREATED:20230208T195958Z
LAST-MODIFIED:20230208T195958Z
UID:10000357-1676548800-1676552400@ctl.cornell.edu
SUMMARY:Due Diligence on Investors - Webinar
DESCRIPTION:On Thursday\, February 16\, noon – 1 pm ET\, Weill Cornell Medicine Enterprise Innovation is hosting a virtual program to find out the types of questions founders need to ask before approaching investors\, as well as what to expect in a long-term partnership. This is the second event that will kick off the 2023 Startup Symposium & InvestConnect Conference\, scheduled for Thursday\, February 23.  \nClick HERE to RSVP for Due Diligence on Investors \n ———- \nModerator: \nLiz Hamburg\, MBA\, Founder & President\, Candoo Tech \nPanelists: \n\nRobert Ang\, MBBS\, MBA\, CEO\, Vor Bio\nSumayah Jamal\, MD-PhD\, President\, Co-founder\, CSO\, ENB Therapeutics\nKatherine Saunders\, MD\, DABOM\, Executive VP\, Senior Medical Officer\, Intellihealth
URL:https://ctl.cornell.edu/event/due-diligence-on-investors-webinar
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/02/Due-diligence-Events-page-image-size-700x500px-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230209T120000
DTEND;TZID=UTC:20230209T130000
DTSTAMP:20260429T044509
CREATED:20230207T210555Z
LAST-MODIFIED:20230207T210754Z
UID:10000355-1675944000-1675947600@ctl.cornell.edu
SUMMARY:Hiring a Scientific Team - Webinar
DESCRIPTION:On Thursday\, February 9\, noon – 1 pm ET\, Weill Cornell Medicine Enterprise Innovation is hosting a virtual program with Dr. Yulia Sapir-Lekhovitser\, CSO of Cornell Startup Fesarius Therapeutics. Dr. Sapir-Lekhovitser will lead a discussion on “Hiring a Scientific Team\,” including tips on hiring scientific talent\, best practices in the hiring process\, places to find top talent\, and unique questions to ask interviewees. This event will kick off the 2023 Startup Symposium & InvestConnect Conference\, scheduled for Thursday\, February 23.  \nClick HERE to RSVP for Hiring a Scientific Team \n ———- \nFesarius has developed a patented micro-architecture construct that solves many clinical shortcomings in soft tissue repair.  Its lead product\, DermiSphere™\, is a collagen micropatterned dermal template that is designed to provide a means to repair severe\, full-thickness dermal loss in a single procedure\, rather than the current standard of two procedures separated by 14-28 days.
URL:https://ctl.cornell.edu/event/hiring-a-scientific-team-webinar
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/02/Events-page-image-size-700x500px-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221114T150000
DTEND;TZID=UTC:20221114T173000
DTSTAMP:20260429T044509
CREATED:20221102T005142Z
LAST-MODIFIED:20221102T005142Z
UID:10000296-1668438000-1668447000@ctl.cornell.edu
SUMMARY:Sixth Annual Symposium on Entrepreneurship and Academic Drug Development
DESCRIPTION:Annual symposium organized by WCM Enterprise Innovation and the Dean’s Office on entrepreneurship and drug and device development. This year’s keynote speaker is George Church\, Professor of Genetics at Harvard Medical School and Massachusetts Institute of Technology. We are also introducing a new feature: pre-symposium workshops on resources for developing novel therapeutics. \n  \nRegister here.
URL:https://ctl.cornell.edu/event/sixth-annual-symposium-on-entrepreneurship-and-academic-drug-development
LOCATION:Belfer Research Building\, 413 E 69th St\, New York\, NY\, NY\, 10021\, United States
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2022/11/EI-Events-page-image-size-700x500px.png
END:VEVENT
END:VCALENDAR